Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
09 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-second-quarter-2025-financial-results-302501556.html
30 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-initiation-of-phase-1-clinical-study-evaluating-nbip-01435-a-long-acting-corticotropin-releasing-factor-type-1-receptor-antagonist-302494787.html
27 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-post-hoc-data-analyses-from-kinect-hd-study-demonstrating-significant-reduction-in-disease-burden-with-ingrezza-valbenazine-capsules-for-huntingtons-disease-chorea-302492855.html
20 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-data-showing-significant-patient-reported-improvements-in-health-related-quality-of-life-with-ingrezza-valbenazine-capsules-in-older-adults-with-tardive-dyskinesia-302485804.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3092403/0/en/Nxera-Pharma-to-Receive-US-15-Million-from-Neurocrine-Biosciences-Following-Dosing-of-First-Patient-in-Phase-3-Trial-of-NBI-1117568.html
02 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-patient-reported-outcomes-from-kinect-pro-study-demonstrating-ingrezza-valbenazine-capsules-improved-functionality-and-quality-of-life-in-patients-with-tardive-dyskinesia-302469889.html
ABOUT THIS PAGE